Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View

Nanjing MeiRui Pharma Co. Ltd

http://www.meirui.com

Latest From Nanjing MeiRui Pharma Co. Ltd

Deal Watch: Bristol Shores Up Cancer, NASH Pipelines With International Deals

Bookmark
  • Analysis
By Joseph Haas, Ying Huang and Sukaina Virji

Partnership with France’s Enterome will add a microbiome aspect to Bristol’s immuno-oncology efforts, while its license of Japanese firm Nitto Denko’s siRNA technology could bolster NASH combo therapy development. Meanwhile, Eagle moves into biosimilars with the purchase of Arsia for up to $78m.

Business Strategies Commercial
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Medical Devices
    • Monitoring Equipment & Devices
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By